Rapid weight loss outpaces the skins ability to remodel, and substrate availability tightens
AOD 9604 Dosage and Protocol: What the Research Supports The standard research protocol for AOD 9604 is 300 mcg per day, administered via subcutaneous injection
Has been shown to help treat patients with depression, anxiety and OCD
By selectively blocking NNMT, 5-Amino-1MQ is investigated for its ability to preserve cellular NAD+ pools, reduce methylation of nicotinamide to inactive 1-methylnicotinamide (1-MNA), and enhance sirtuin activity and energy metabolism
This product is not a drug, food, or cosmetic and may not be misbranded, misused, or mislabeled as a drug, food, or cosmetic
If you have questions about B12 injections, contact us by calling 561-235-0100 or emailing us at [email protected]